Recombinant multi-species PI3 Kinase p110 Alpha/PIK3CA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PI3 Kinase p110 Alpha/PIK3CA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
The Alternative Names of target: 5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha (PtdIns-3-kinase subunit p110-alpha,5-bisphosphate 3-kinase catalytic subunit alpha isoform,6330412C24Rik,CCM4,CLAPO,CLOVE,CWS5,HMH,MCAP,MCM,MCMTC,PI3 Kinase p110 Alpha,PI3-kinase subunit alpha,PI3K,PI3K-alpha,PI3Kalpha,PIK3CA,Phosphatidylinositol 4,Phosphoinositide 3-kinase alpha,Phosphoinositide-3-kinase catalytic alpha polypeptide,Pik3ca,PtdIns-3-kinase subunit alpha,Serine/threonine protein kinase PIK3CA,caPI3K,p110,p110-alpha,p110alpha,p110alpha)
Go
to PI3 Kinase p110 Alpha/PIK3CA products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T80276-Ag-1/ GM-Tg-hg-T80276-Ag-2 | Human PI3 Kinase p110 Alpha/PIK3CA protein | Human |
| GM-Tg-rg-T80276-Ag-1/ GM-Tg-rg-T80276-Ag-2 | Rat PI3 Kinase p110 Alpha/PIK3CA protein | Rat |
| GM-Tg-mg-T80276-Ag-1/ GM-Tg-mg-T80276-Ag-2 | Mouse PI3 Kinase p110 Alpha/PIK3CA protein | Mouse |
| GM-Tg-cynog-T80276-Ag-1/ GM-Tg-cynog-T80276-Ag-2 | Cynomolgus/Rhesus macaque PI3 Kinase p110 Alpha/PIK3CA protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T80276-Ag-1/ GM-Tg-felg-T80276-Ag-2 | Feline PI3 Kinase p110 Alpha/PIK3CA protein | Feline |
| GM-Tg-cang-T80276-Ag-1/ GM-Tg-cang-T80276-Ag-2 | Canine PI3 Kinase p110 Alpha/PIK3CA protein | Canine |
| GM-Tg-bovg-T80276-Ag-1/ GM-Tg-bovg-T80276-Ag-2 | Bovine PI3 Kinase p110 Alpha/PIK3CA protein | Bovine |
| GM-Tg-equg-T80276-Ag-1/ GM-Tg-equg-T80276-Ag-2 | Equine PI3 Kinase p110 Alpha/PIK3CA protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T80276-Ag-1/ GM-Tg-hg-T80276-Ag-2;
GM-Tg-rg-T80276-Ag-1/ GM-Tg-rg-T80276-Ag-2;
GM-Tg-mg-T80276-Ag-1/ GM-Tg-mg-T80276-Ag-2; GM-Tg-cynog-T80276-Ag-1/ GM-Tg-cynog-T80276-Ag-2; GM-Tg-felg-T80276-Ag-1/ GM-Tg-felg-T80276-Ag-2; GM-Tg-cang-T80276-Ag-1/ GM-Tg-cang-T80276-Ag-2; GM-Tg-bovg-T80276-Ag-1/ GM-Tg-bovg-T80276-Ag-2; GM-Tg-equg-T80276-Ag-1/ GM-Tg-equg-T80276-Ag-2 |
| Products Name | PI3 Kinase p110 Alpha/PIK3CA protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PI3 Kinase p110 Alpha/PIK3CA |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PI3 Kinase p110 Alpha/PIK3CA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.